Loading stock data…
MiniMed Group (MMED)
$14.88+0.64 (+4.49%)
After Hours$14.88+0.00 (+0.00%)· Last close Jun 29
MiniMed Group, Inc.
Historical Price
Price (Candle)
Synthesizing Whystock Narrative...
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Total Revenue | $790.00M | — | $724.00M↑ | $687.00M |
| Gross Profit | $362.00M | — | $402.00M↑ | $395.00M |
| Operating Income | -$93.00M | — | -$38.00M↓ | $22.00M |
| Net Income | -$119.00M | — | -$209.00M↓ | -$10.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, including insulin pumps and pe...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.22B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-9.76%
Volume
Today's trading volume
1.32M
Recent News
This Undervalued Medical-Devices Stock Is Poised for a Rebound
Medtronic is deeply undervalued and a good bet for your portfolio. At the time, an uncertain growth outlook kept us from recommending the stock. Four months later, it’s time to retire the narrative of Medtronic as a perpetual laggard.
A Look At MiniMed Group (MMED) Valuation After Recent Share Price Volatility
MiniMed Group stock in focus MiniMed Group (MMED) has caught investor attention after a recent move in its share price, prompting a closer look at how its current valuation lines up with recent performance and fundamentals. See our latest analysis for MiniMed Group. Recent trading has been volatile, with a 1-day share price return of 4.57% and a 7-day share price return of 24.00%. However, the year to date share price return of 19.52% indicates earlier weakness, suggesting momentum is only...
Medtronic Bottoms, Healthy Rebound Ahead
Medtronic is on track to reverse after a major market meltdown driven by fear. The upside potential is double-digit, not including the dividend.
Minimed Group Inc (MMED) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Product ...
Minimed Group Inc (MMED) surpasses $3 billion in revenue for fiscal 2026, driven by strong international performance and innovative product introductions.
Medtronic Stock Is Defying a Market Selloff After Earnings. Here’s Why.
The medical device maker posts fiscal fourth-quarter earnings and revenue that narrowly beat analysts’ estimates.